ClinicalThought

Share

Program Content

Activities

  • MM Frontline Tx
    My Thoughts on the Current Standard of Care for Newly Diagnosed Myeloma
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: August 09, 2019

    Expires: August 07, 2020

  • New Agents for RR Myeloma
    Promising New Agents for Patients With Relapsed/Refractory Myeloma
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: October 30, 2019

    Expires: October 28, 2020

  • Considerations for R/R Myeloma
    Considerations for Relapsed/Refractory Myeloma: What I Do in My Practice
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: January 31, 2020

    Expires: January 29, 2021

  • Myeloma During COVID-19
    How I Am Managing My Patients With Myeloma During the COVID-19 Pandemic
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: April 28, 2020

    Expires: April 27, 2021

Faculty

cover img faculity

Sarah A. Holstein, MD, PhD

Professor of Medicine
Division of Oncology and Hematology
University of Nebraska Medical Center
Omaha, Nebraska

cover img faculity

Suzanne Lentzsch, MD, PhD

Director, Multiple Myeloma and Amyloidosis Program
Associate Professor of Medicine
Division of Hematology/Oncology
Columbia University Medical Center
New York, New York

cover img faculity

Elisabet E. Manasanch, MD

Leader, Early Myeloma Program
Director, Myeloma Tissue Bank
Tenured Associate Professor
University of Texas MD Anderson Cancer Center
Houston, Texas

Provided by

ProCE Banner

Supporters

AbbVie

Amgen, Inc.

Celgene

Janssen administered by Scientific Affairs

Oncopeptides